| ²é¿´: 6561 | »Ø¸´: 14 | |||
| ±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
mhx000½ð³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇëÎÊÔõôÔÚFDAÍøÕ¾ÉϲéÒ»¸öÒ©Îï±»Åú×¼µÄʱ¼ä°¡£¬»òÕßÖªµÀËü...
|
||
| ÇëÎÊÔõôÔÚFDAÍøÕ¾ÉϲéÒ»¸öÒ©Îï±»Åú×¼µÄʱ¼ä°¡£¬»òÕßÖªµÀËüµÄÑз¢¹«Ë¾£¬ÊÇÔÚ¹«Ë¾Ö÷Ò³ÉϲéÂð£¿Ð»Ð»À²~ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ò§çïҩѧ |
» ²ÂÄãϲ»¶
µ÷¼Á
ÒѾÓÐ16È˻ظ´
»¯Ñ§¹¤³Ìµ÷¼Á289
ÒѾÓÐ23È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁÏר˶µ÷¼Á
ÒѾÓÐ10È˻ظ´
328Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
266Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
278Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
259Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸0703»¯Ñ§ÕÐ61×îÖÕÅÅÃû62»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- LS-EPI: 4
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
452612957: ½ð±Ò+1, ллӦÖú£¬¹ÄÀøÒ»ÏÂ~ 2012-06-05 12:25:06
452612957: ½ð±Ò+1, ллӦÖú£¬¹ÄÀøÒ»ÏÂ~ 2012-06-05 12:25:06
|
·½·¨Ò»£º http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm ÔÚËÑË÷¿òÀïÊäÈëÄãÒª²éÕÒµÄÒ©Æ·Ãû³Æ£¬µÈËÑË÷½á¹û³öÀ´Ö®ºó£¬¿ÉÄÜÊÇÒ»´®»òÕßÒ»¸ö£¬Ñ¡ÖÐÄãÒªµÄÄǸö£¬½øÈëµ½¸ÃÒ©µÄdrug detailsÒ³Ãæ£¬Ñ¡µÚ¶þÇøÓÒ²àµÄLabel Information£¬ÓгöÏÖһϵÁеÄÐÅÏ¢£¬°üÀ¨ËµÃ÷Êé¡£ ·½·¨¶þ£º£¨¼«Á¦ÍƼö£© ÃÀ¹úFDAÒ©Æ·Êý¾Ý¿â http://www.drugfuture.com/fda/ ÊäÈëÏàÓ¦ÐÅÏ¢¼´¿É£¬¼ìË÷ºÜ¼òµ¥¡£²»¶à˵¡£½øÈëºó»áÓÐÏàÓ¦µÄFDAÔøÅú×¼¹ýÉÏÊеÄËùÓÐÒ©Îï¡£Êг¡×´Ì¬¡¢ÉÏÊÐʱ¼ä¡¢¼ÁÐ͹æ¸ñµÈһĿÁËÈ» |

3Â¥2012-06-05 09:14:32
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- LS-EPI: 4
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
black467: ½ð±Ò+2, ¼ìË÷EPI+1, ÓмÛÖµ»ØÌû ½±ÀøEPI »¶Ó³£À´ 2012-06-05 21:53:39
mhx000: ½ð±Ò+7, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-06-05 22:05:33
black467: ½ð±Ò+2, ¼ìË÷EPI+1, ÓмÛÖµ»ØÌû ½±ÀøEPI »¶Ó³£À´ 2012-06-05 21:53:39
mhx000: ½ð±Ò+7, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-06-05 22:05:33
|
È«Çò·¶Î§ÄÚ¶¼Ã»»¹ÉÏÊУ¬ËùÒÔFDAûÄܼìË÷µ½¡£ Ñз¢½×¶ÎµÄÊý¾Ý£¬Ðè²éѯÌÀÄ·ÉÊý¾Ý¿â¼°PharmaprojectsÊý¾Ý¿â¡£ ¶¼ÒѾ²é¹ýÁË£¬×ÊÁϼû¸½¼þ ÌÀÄ·ÉÊý¾Ý£¨ÍøÂç°æ£©£º http://g.zhubajie.com/urllink.php?id=12410423rwul8bmribwdi4m2 PharmaprojectsÊý¾Ý£º http://g.zhubajie.com/urllink.php?id=1241042819bt31gs9i3rfpfd |

8Â¥2012-06-05 16:46:32
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- LS-EPI: 4
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
|
http://g.zhubajie.com/urllink.php?id=12411730ayre0m8ztqfqsl34 word°æ£¬Ö±½Ó¸´ÖÆð¤ÌùµÄ¡£¡£¡£ |

13Â¥2012-06-05 22:46:43
xuyy1
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 2044.4
- É¢½ð: 21
- ºì»¨: 5
- Ìû×Ó: 646
- ÔÚÏß: 134Сʱ
- ³æºÅ: 786495
- ×¢²á: 2009-06-04
- ÐÔ±ð: MM
- רҵ: Ò©Îï¶¾Àí

2Â¥2012-06-05 08:43:33
mhx000
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 628.7
- É¢½ð: 177
- ºì»¨: 5
- Ìû×Ó: 388
- ÔÚÏß: 160.9Сʱ
- ³æºÅ: 1441299
- ×¢²á: 2011-10-13
- ÐÔ±ð: MM
- רҵ: ΢ÉúÎïÒ©Îï
4Â¥2012-06-05 10:41:38
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- LS-EPI: 4
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ

5Â¥2012-06-05 11:06:47
mhx000
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 628.7
- É¢½ð: 177
- ºì»¨: 5
- Ìû×Ó: 388
- ÔÚÏß: 160.9Сʱ
- ³æºÅ: 1441299
- ×¢²á: 2011-10-13
- ÐÔ±ð: MM
- רҵ: ΢ÉúÎïÒ©Îï
6Â¥2012-06-05 16:26:06
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- LS-EPI: 4
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Biosensors has developed and launched a drug¨Celuting stent (DES) consisting of the BioMatrix (Biofreedom) stent platform with a biodegradable polymer coating, designed to deliver umirolimus (Biolimus A9, BA9, TRM-986), an immunosuppressant and anti-inflammatory rapamycin derivative, for the treatment of restenosis , 11 In April 2008, BioMatrix was launched in Europe and several major markets in the Middle East, Africa and Asia . In May 2010, an extension product, the BioMatrix Flex stent, incorporating a new stent platform, was launched in major European markets and selected regions in the Middle East, Africa and Asia. |

7Â¥2012-06-05 16:39:50
mhx000
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 628.7
- É¢½ð: 177
- ºì»¨: 5
- Ìû×Ó: 388
- ÔÚÏß: 160.9Сʱ
- ³æºÅ: 1441299
- ×¢²á: 2011-10-13
- ÐÔ±ð: MM
- רҵ: ΢ÉúÎïÒ©Îï
9Â¥2012-06-05 22:02:44
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- LS-EPI: 4
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ

10Â¥2012-06-05 22:07:32














»Ø¸´´ËÂ¥
ÕâÑùÌ«ÄÑÁË¡£Ò©Æ·ÃûÓÐÂ𣿻òÕßÑз¢´úÂë¡£
£¬µÚ¶þ¸öÊý¾ÝºÜÓаïÖú£¬²»¹ýµÚÒ»¸öÊý¾Ý´ò²»¿ªÑ½